Maryland 2025 Regular Session

Maryland Senate Bill SB810

Introduced
2/3/25  
Refer
2/3/25  
Report Pass
3/14/25  
Engrossed
3/17/25  
Refer
3/17/25  
Report Pass
4/4/25  
Enrolled
4/7/25  
Chaptered
5/20/25  

Caption

Board of Trustees for the State Retirement and Pension System - Investment Division - Compensation and Staffing

Summary

SB810 revises how the Board of Trustees for the State Retirement and Pension System oversees compensation, staffing, and incentive pay within the Investment Division of the State Retirement Agency. The bill renames the existing Objective Criteria Committee as the Compensation and Staffing Committee, updates its membership, and expands its role to make recommendations on the qualifications, compensation, staffing levels, and financial incentives for the Chief Investment Officer and other Investment Division employees. It also clarifies that the Board may establish additional committees and may use a consultant to assist the committee and the Board, including for executive search services. The bill also makes several changes to the rules governing incentive compensation. It clarifies when incentive payments may continue after separation from employment, including for employees who retire directly from the Investment Division within 30 days of separation. It preserves restrictions tied to furloughs, objective performance benchmarks, and limits on compensation increases, while adding reporting requirements to the General Assembly on adopted criteria, changes to compensation and incentives, and quarterly investment performance by asset class and by employee. The act takes effect July 1, 2025.

Impact

SB810 amends provisions in the State Personnel and Pensions Article governing the State Retirement and Pension System’s Investment Division, especially §§ 21-108, 21-118.1, and 21-122. It changes the internal governance structure for setting pay and staffing by replacing the Objective Criteria Committee with a Compensation and Staffing Committee, broadening the Board’s authority over positions and compensation, and requiring more detailed legislative reporting. The bill affects the Board of Trustees, the Executive Director, the Chief Investment Officer, Investment Division staff, and the General Assembly committees that receive annual and quarterly reports.

Sentiment

The bill appears to have been broadly supported and noncontroversial in the recorded votes, passing the Senate 42-0 and the House 136-0. The absence of committee transcript material suggests there is no recorded public debate in the provided materials, and the unanimous roll-call results indicate consensus around the need to update compensation and staffing oversight for the Investment Division. Overall, the sentiment reflected in the available history is favorable and procedural rather than divisive.

Contention

The main policy issues addressed by the bill are how much discretion the Board should have over compensation, whether incentive pay should continue after retirement or separation, and how independent the committee should be from the Chief Investment Officer and outside consultants. The bill narrows some prior structures by removing the public member from the committee and shifting to a Board-centered membership model, while also allowing executive-search consulting but prohibiting the CIO from separately retaining the same consultant. Any potential contention would likely center on executive compensation, transparency, and the balance between investment-market competitiveness and public-sector pay controls, though no recorded opposition appears in the provided vote history.

Companion Bills

MD HB1028

Crossfiled Caroline County Board of Education - Member Compensation - Increase

Similar Bills

US HR198

Providing for the expenses of certain committees of the House of Representatives in the One Hundred Nineteenth Congress.

MN HC1

A house concurrent resolution relating to the regent nomination joint committee.

IL HR0020

HOUSE RULES-AMEND

CA AB1350

Employment Development Department: policies and practices.

NM HJM2

Combine Standing & Interim Committees

MN HC2

A House concurrent resolution relating to the adjournment of the House of Representatives and Senate until 2026.

CA SB829

California Institute for Scientific Research: CalRx Initiative: vaccines.

AR HB1573

To Reorganize The Standing Committees And The Subject Matter Interim Committees Of The House Of Representatives.